In chronic myeloid leukemia (CML), both total and phosphorylation levels of CaMK2γ were highly increased in CD34 + /CD38− leukemia stem cells (LSCs) but not in CD34- CML cells and normal hematopoietic cells (HSCs). Here, CAMK2G is linked to chronic myelogenous leukemia, BCR-ABL1 positive.